Effect of ABCG2 genotypes on the pharmacokinetics of A771726, an active metabolite of prodrug leflunomide, and association of A771726 exposure with serum uric acid level.
about
Role of the breast cancer resistance protein (BCRP/ABCG2) in drug transport--an update.Semiphysiologically Based Pharmacokinetic Model of Leflunomide Disposition in Rheumatoid Arthritis Patients.Polymorphisms in cytochrome P450 2C19 enzyme and cessation of leflunomide in patients with rheumatoid arthritis.Effect of the ATP-binding cassette transporter ABCG2 on pharmacokinetics: experimental findings and clinical implications.Pharmacokinetic evaluation of teriflunomide for the treatment of multiple sclerosis.Metabolic and safety issues for multiple sclerosis pharmacotherapy--opportunities for personalised medicine.Pharmacogenetics and immunosuppressive drugs.Pre-Plated Cell Lines for ADMETox Applications in the Pharmaceutical Industry.Quantification of the steady-state plasma concentrations of clozapine and N-desmethylclozapine in Japanese patients with schizophrenia using a novel HPLC method and the effects of CYPs and ABC transporters polymorphisms.Renal Drug Transporters and Drug Interactions.Clinical Pharmacokinetic Monitoring of Leflunomide in Renal Transplant Recipients with BK Virus Reactivation: A Review of the Literature.Intracellular CD3+ T Lymphocyte Teriflunomide Concentration Is Poorly Correlated with and Has Greater Variability Than Unbound Plasma Teriflunomide Concentration.
P2860
Q34871636-6301524F-72CF-466C-9D0D-E4FC290DB87FQ35861714-53868B71-99BC-4308-8EAC-FCBCBF4DE04DQ36633307-D113CD9E-74F8-4872-A616-4E438B106D56Q38071700-59397CC4-04B3-4EE6-A649-775377402AF7Q38107524-0E72F979-C053-478E-9C76-D2347DFA6D1AQ38218692-B094AE01-71BA-44E1-A84A-6BE36EC903BFQ38258677-E94EBB4F-B595-428F-AEF7-49903E14B484Q38845725-D592F477-B562-4006-90EA-46B727449D7BQ39117848-181A1092-7207-4A5B-873F-F97DF76756ABQ39140289-0B3727CA-3B78-49D7-8DCF-F59DEE6FDC3AQ39155699-7F91A2A8-E7C7-42EE-9348-B9F9FC6860A6Q51771540-C2EEC4AA-8D71-4085-AC39-2B969806F855
P2860
Effect of ABCG2 genotypes on the pharmacokinetics of A771726, an active metabolite of prodrug leflunomide, and association of A771726 exposure with serum uric acid level.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Effect of ABCG2 genotypes on t ...... re with serum uric acid level.
@en
Effect of ABCG2 genotypes on t ...... re with serum uric acid level.
@nl
type
label
Effect of ABCG2 genotypes on t ...... re with serum uric acid level.
@en
Effect of ABCG2 genotypes on t ...... re with serum uric acid level.
@nl
prefLabel
Effect of ABCG2 genotypes on t ...... re with serum uric acid level.
@en
Effect of ABCG2 genotypes on t ...... re with serum uric acid level.
@nl
P2093
P2860
P1476
Effect of ABCG2 genotypes on t ...... re with serum uric acid level.
@en
P2093
Hyun-Jin Joo
Ji-Young Park
Kyoung-Ah Kim
P2860
P2888
P304
P356
10.1007/S00228-010-0916-0
P577
2010-10-23T00:00:00Z